Houston second-round draft pick John Metchie was recently diagnosed with leukemia and will most likely miss his rookie season in 2022. The Texans announced the news earlier today in a statement.
Fortunately for Metchie, his diagnosis of Acute Promyelocytic Leukemia (APL) is the most curable form of the disease. Unfortunately for him and the Texans, he “will likely not be playing football this season.”
APL is a cancer of the blood-forming tissue (bone marrow). Ninety percent of patients achieve complete remission, according to the Leukemia and Lymphoma Society.
Houston traded three draft picks to move up 24 spots to select the former Alabama wide receiver with the No. 44 overall pick. Metchie might have missed parts of the year anyway after tearing his ACL on Dec. 4 in the Crimson Tide’s 41-24 win over Georgia at the SEC Championship Game.
In 2020, Metchie hauled in 55 receptions for 916 yards and six touchdowns. In 13 games this past season, he had 96 catches for 1,142 yards and eight TDs.